Prevalence of arteriovenous fistula use in hemodialysis patients in Burdur province

Abstract

Objective: This study aimed to examine the vascular access routes used by patients undergoing hemodialysis treatment in our province and determine the prevalence of arteriovenous (AV) fistula use.

Methods: Patients who were receiving regular hemodialysis treatment in Burdur province as of April 2024 were included in the study. Data on patients' age, gender, comorbidities, duration of dialysis, type of vascular access, and history of hemodialysis access were retrospectively reviewed and recorded using electronic patient records.

Results: The mean age of 197 patients evaluated in the study was 62.48±14.13 years. Of the patients, 63 (32%) were female and 134 (68%) were male. Hypertension was the most common comorbidity in 61.9% of the cases. The number of patients receiving hemodialysis treatment through an AV fistula was 136 (69%). The mean age of patients receiving treatment via an AV fistula was significantly lower than those receiving treatment via an indwelling hemodialysis catheter (P=0.011). Among the patients treated with an indwelling hemodialysis catheter, 59% had no history of AV fistula surgery. The mean age of patients without a history of AV fistula surgery was statistically significantly higher than those with a history of AV fistula surgery (69.28±14.98 vs. 60.96±13.52, respectively; P=0.001).

Conclusions: This study shows that one out of every two patients undergoing hemodialysis through an indwelling hemodialysis catheter has no history of AV fistula surgery. Reaching these patients and prioritizing AV fistula planning is crucial for achieving long-term success in hemodialysis treatment and reducing complications.

Keywords

• Cardiovascular surgery
• nephrology
• arteriovenous fistula
• hemodialysis

References

1. 1. Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int. 2019;96(5):1048-1050. doi: 10.1016/j.kint.2019.07.012.
2. 2. Laupacis A, Keown P, Pus N, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int. 1996;50(1):235-242. doi: 10.1038/ki.1996.307.
3. 3. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725-1730. doi: 10.1056/NEJM199912023412303.
4. 4. Loubeau PR, Loubeau JM, Jantzen R. The economics of kidney transplantation versus hemodialysis. Prog Transplant. 2001;11(4):291-297. doi: 10.1177/152692480101100411.
5. 5. Casserly LF, Dember LM. Thrombosis in end-stage renal disease. Semin Dial. 2003;16(3):245-256. doi: 10.1046/j.1525-139X.2003.16048.x.
6. 6 Roy-Chaudhury P, Kelly BS, Melhem M, et al. Vascular access in hemodialysis: issues, management, and emerging concepts. Cardiol Clin. 2005;23(3):249-273. doi: 10.1016/j.ccl.2005.04.004.
7. 7. Brescia MJ, Cimino JE, Appel K, Hurwich BJ. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med. 1966;275(20):1089-1092. doi: 10.1056/NEJM196611172752002.
8. 8. Manduz Ş, Katrancıoğlu N, Karahan O, Sapmaz İ, Doğan K. [Results of A-V Fistula Creation Surgeries for Hemodialysis Purposes Performed in Cumhuriyet University, Faculty of Medicine, Department of Cardiovascular Surgery]. Cumhuriyet Med J. 2008;30(1):28-32. [Article in Turkish]

9. 9. Hastaoglu IO, Bilgen F. [Basilic vein transposition performed for hemodialysis access: Mid-term results]. Turk Gogus Kalp Damar Cerrahisi Derg. 2011;19(4):513-517. doi: 10.5606/tgkdc.dergisi.2011.079. [Article in Turkish]
10. 10. Vats HS. Complications of catheters: tunneled and nontunneled. Adv Chronic Kidney Dis. 2012;19(3):188-194. doi: 10.1053/j.ackd.2012.04.004.
11. 11. Bhutta ST, Culp WC. Evaluation and management of central venous access complications. Tech Vasc Interv Radiol. 2011;14(4):217-224. doi: 10.1053/j.tvir.2011.05.003.
12. 12. Poinen K, Quinn RR, Clarke A, et al. Complications From Tunneled Hemodialysis Catheters: A Canadian Observational Cohort Study. Am J Kidney Dis. 2019;73(4):467-475. doi: 10.1053/j.ajkd.2018.10.014.
13. 13. Depner TA. Catheter performance. Semin Dial. 2001;14(6):425-431. doi: 10.1046/j.1525-139x.2001.00106.x.
14. 14. Roldão M, Figueiredo C, Escoli R,et al. Vascular access type and mortality in elderly incident hemodialysis patients. Nefrologia (Engl Ed). 2023;43(4):452-457. doi: 10.1016/j.nefroe.2022.02.011.
15. 15. Kim DH, Park JI, Lee JP, et al. The effects of vascular access types on the survival and quality of life and depression in the incident hemodialysis patients. Ren Fail. 2020;42(1):30-39. doi: 10.1080/0886022X.2019.1702558.
16. 16. Jenkins AM, Buist TA, Glover SD. Medium-term follow-up of forty autogenous vein and forty polytetrafluoroethylene (Gore-Tex) grafts for vascular access. Surgery. 1980;88(5):667-672.
17. 17. Lawson JH, Niklason LE, Roy-Chaudhury P. Challenges and novel therapies for vascular access in haemodialysis. Nat Rev Nephrol. 2020;16(10):586-602. doi: 10.1038/s41581-020-0333-2.
18. 18. Seyahi N, Kocyigit İ, Eren N, et al. Current status of kidney replacement therapy in Türkiye: A summary of 2022 Turkish Society of Nephrology registry report. Turk J Nephrol. 2024;33(2):134-139. doi: 10.5152/turkjnephrol.2024.24722.
19. 19. Asif A, Bakr MM, Levitt M, et al. Best Vascular Access in the Elderly: Time for Innovation? Blood Purif. 2019;47(1-3):236-239. doi: 10.1159/000494591.
20. 20. Contreras-Jimenez E, Lopez-Pena G, Ruben-Castillo C, et al. Analysis of clinical outcomes of arteriovenous fistula for hemodialysis access in a Mexican elderly population. Cir Cir. 2023;91(2):200-203. English. doi: 10.24875/CIRU.22000217.